title: Infliximab in the treatment of rheumatoid meningoencephalitis.
authors.forename: Felix
authors.initials: F
authors.lastname: Luessi
authors.forename: Janina
authors.initials: J
authors.lastname: Sollors
authors.forename: Harald
authors.initials: H
authors.lastname: Müller
authors.forename: Peter
authors.initials: P
authors.lastname: Stoeter
authors.forename: Clemens
authors.initials: C
authors.lastname: Sommer
authors.forename: Thomas
authors.initials: T
authors.lastname: Vogt
authors.forename: Frank
authors.initials: F
authors.lastname: Birklein
authors.forename: Frank
authors.initials: F
authors.lastname: Thömke
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000175:diagnosis / Q000276:immunology; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D000069285:Infliximab; D008590:Meningoencephalitis / Q000188:drug therapy* / Q000209:etiology* / Q000276:immunology; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab
references.citation: Neurology. 2007 Mar 27;68(13):1079-80
references.pmid: 17389318
references.citation: J Rheumatol. 2005 Jan;32(1):181-3
references.pmid: 15630746
references.citation: Ann Rheum Dis. 2006 Aug;65(8):1114-6
references.pmid: 16837495
references.citation: J Neurol. 2004 Jun;251(6):760-1
references.pmid: 15311358
references.citation: Arthritis Rheum. 1988 Mar;31(3):315-24
references.pmid: 3358796
references.citation: Clin Rheumatol. 2003 Dec;22(6):475-80
references.pmid: 14677033
references.citation: Semin Arthritis Rheum. 1989 May;18(4):258-66
references.pmid: 2658068